Longitudinal analysis of antibody decay in convalescent COVID-19 patients

Weiming Xia, Mingfei Li, Ying Wang, Lewis E. Kazis, Kim Berlo, Noureddine Melikechi, Gregory R. Chiklis

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


Determining the sustainability of antibodies targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential for predicting immune response against the Coronavirus disease 2019 (COVID-19). To quantify the antibody decay rates among the varying levels of anti-nucleocapsid (anti-N) Immunoglobulin G (IgG) in convalescent COVID-19 patients and estimate the length of time they maintained SARS-CoV-2 specific antibodies, we have collected longitudinal blood samples from 943 patients over the course of seven months after their initial detection of SARS-CoV-2 virus by RT-PCR. Anti-N IgG levels were then quantified in these blood samples. The primary study outcome was the comparison of antibody decay rates from convalescent patients with high or low initial levels of antibodies using a mixed linear model. Additional measures include the length of time that patients maintain sustainable levels of anti-N IgG. Antibody quantification of blood samples donated by the same subject multiple times shows a gradual decrease of IgG levels to the cutoff index level of 1.4 signal/cut-off (S/C) on the Abbott Architect SARS-CoV-2 IgG test. In addition, this study shows that antibody reduction rate is dependent on initial IgG levels, and patients with initial IgG levels above 3 S/C show a significant 1.68-fold faster reduction rate compared to those with initial IgG levels below 3 S/C. For a majority of the donors naturally occurring anti-N antibodies were detected above the threshold for only four months after infection with SARS-CoV-2. This study is clinically important for the prediction of immune response capacity in COVID-19 patients.

Original languageEnglish (US)
Article number16796
Pages (from-to)16796
JournalScientific Reports
Issue number1
StatePublished - Aug 18 2021


  • Antibodies, Viral/blood
  • COVID-19/immunology
  • Female
  • Humans
  • Immunoglobulin G/immunology
  • Linear Models
  • Longitudinal Studies
  • Male

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Longitudinal analysis of antibody decay in convalescent COVID-19 patients'. Together they form a unique fingerprint.

Cite this